| 崙棫堛栻昳怘昳塹惗尋媶強 |
National Institute of Health Sciences |
| 惗暔栻昳晹 |
Division of Biological Chemistry and Biologicals |
|
丂丂丂 |
亂rINN亃intetumumab (List 63, 2010, Vol.24, No. 1, p61)
亂pINN亃intetumumab (List 101, 2009, Vol.23, No. 2, p151)
亂夝愢乮榓栿乯亃
IgG1內, 峈僸僩僀儞僥僌儕儞兛-V (CD51, ITGAV, alphaV-beta3 僒僽儐僯僢僩, CD51/CD61, 價僩儘僱僋僠儞庴梕懱
枖偼 VNR, alphaV-beta5 僒僽儐僯僢僩), 僸僩儌僲僋儘乕僫儖峈懱; 峈庮釃栻丏
H嵔 (兞1嵔丆1-449)丗[Homo sapiens VH (IGHV3-30*01 (91.80%) -(IGHD)-IGHJ3*02)
[8.8.12] (1-119) -IGHG1*01 (120-449)]丏
L嵔(內嵔丆1'-215')丗[Homo sapiens VKAPPA (IGKV3-11*01 (100.00%) -IGKJ3*01) [6.3.10]
(1'-108') -IGKC*01 (109'-215')]丏
僕僗儖僼傿僪寢崌偺埵抲丗222-215', 228-228''丆231-231''
摐嵔晅壛埵抲丗299, 299''
亂暘巕幃亃C6468H10008N1744O2006S40
亂CAS斣崋亃725735-28-4
亂JAN亃枹廂嵹
|
|
| Copyright (C) 丂丂丂Division of Biological Chemistry and Biologicals丂丂丂All
rights reserved. |
|
|